-
Dr. Reddy's partners with Sanofi for vaccine brands in India
Dr. Reddy’s will have exclusive rights to promote and distribute Hexaxim, Pentaxim, Tetraxim, Menactra, FluQuadri, Adacel and Avaxim 80U. -
CSL Seqirus prepared to deliver 2024/25 U.S. season influenza vaccine portfolio
The vaccine portfolio is based on the trivalent strains recommended by the FDA's Vaccines and Related Biological Products Advisory Committee.